Eesti - eesti - Ravimiamet

johnson & johnson uab - risperidoon - õhukese polümeerikattega tablett - 3mg 60tk; 3mg 20tk; 3mg 50tk; 3mg 100tk

Eesti - eesti - Ravimiamet

johnson & johnson uab - tsinnarisiin - tablett - 25mg 50tk

Eesti - eesti - Ravimiamet

johnson & johnson uab - topiramaat - õhukese polümeerikattega tablett - 200mg 28tk; 200mg 10tk; 200mg 56tk; 200mg 100tk; 200mg 20tk; 200mg 60tk; 200mg 200tk; 200mg 50tk

Eesti - eesti - Ravimiamet

johnson & johnson uab - topiramaat - õhukese polümeerikattega tablett - 100mg 20tk; 100mg 28tk; 100mg 60tk; 100mg 50tk; 100mg 100tk; 100mg 56tk; 100mg 200tk

Eesti - eesti - Ravimiamet

johnson & johnson uab - topiramaat - õhukese polümeerikattega tablett - 50mg 56tk; 50mg 200tk; 50mg 10tk; 50mg 60tk; 50mg 100tk; 50mg 28tk; 50mg 20tk; 50mg 50tk

Eesti - eesti - Ravimiamet

johnson & johnson uab - topiramaat - õhukese polümeerikattega tablett - 25mg 56tk; 25mg 28tk; 25mg 10tk; 25mg 200tk; 25mg 100tk; 25mg 50tk; 25mg 60tk

Eesti - eesti - Ravimiamet

lex ano uab - mebendasool - tablett - 100mg 6tk

Eesti - eesti - Ravimiamet

ideal trade links uab - mebendasool - tablett - 100mg 6tk

Euroopa Liit - eesti - EMA (European Medicines Agency)

biontech manufacturing gmbh - single-stranded, 5’-capped messenger rna produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vaktsiinid - comirnaty 30 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty original/omicron ba. 1 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19. comirnaty original/omicron ba. 4-5 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty original/omicron ba. 4-5 (1. 5/1. 5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty omicron xbb. 5 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty omicron xbb. 5 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 10 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. kasutamist see vaktsiin peaks olema kooskõlas ametlike soovitustega.

Eesti - eesti - Ravimiamet

johnson & johnson uab - metüülfenidaat - toimeainet prolongeeritult vabastav tablett - 36mg 28tk; 36mg 30tk